NCT05509634 2023-10-27
Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3 Completed
Clinical Trials
1 trialsPhase 3 × Interventional × Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy × Clear all